Rotavirus

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

• Rotavirus is a leading cause of gastroenteritis worldwide. The greatest morbidity and mortality is observed among young infants in the developing world. • Fever, vomiting, and diarrhea are the most common signs and symptoms of the disease. • Although highly sensitive and specific antigen assays are commercially available, most diagnoses can be made based on clinical manifestations and will not require diagnostic testing. • Treatment is supportive, with special attention to be placed on the replacement of fluids. In most instances, this goal can be achieved through the use of oral rehydration solutions. • The use of probiotics, oral immunoglobulins, and nitazoxanide has been shown in some studies to be of benefit in children with prolonged diarrhea. However, further studies are needed before these therapies can be recommended for all patients. • The most dramatic effect on disease activity has been observed in countries in which rotavirus vaccination has been incorporated. These vaccines have been shown to be effective and safe. • Widespread vaccination will continue to alter the epidemiology of the disease and will prevent many hospitalizations and save many lives.

Original languageEnglish
Pages (from-to)439-447
Number of pages9
JournalPediatrics in Review
Volume33
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Rotavirus
nitazoxanide
Diarrhea
Vaccination
Rehydration Solutions
Fluid Therapy
Probiotics
Gastroenteritis
Signs and Symptoms
Vomiting
Immunoglobulins
Epidemiology
Hospitalization
Fever
Vaccines
Morbidity
Antigens
Mortality
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Rotavirus. / Cox, Elaine; Christenson, John.

In: Pediatrics in Review, Vol. 33, No. 10, 10.2012, p. 439-447.

Research output: Contribution to journalArticle

Cox, Elaine ; Christenson, John. / Rotavirus. In: Pediatrics in Review. 2012 ; Vol. 33, No. 10. pp. 439-447.
@article{ac2c35814e7a48a588ff0295294636c7,
title = "Rotavirus",
abstract = "• Rotavirus is a leading cause of gastroenteritis worldwide. The greatest morbidity and mortality is observed among young infants in the developing world. • Fever, vomiting, and diarrhea are the most common signs and symptoms of the disease. • Although highly sensitive and specific antigen assays are commercially available, most diagnoses can be made based on clinical manifestations and will not require diagnostic testing. • Treatment is supportive, with special attention to be placed on the replacement of fluids. In most instances, this goal can be achieved through the use of oral rehydration solutions. • The use of probiotics, oral immunoglobulins, and nitazoxanide has been shown in some studies to be of benefit in children with prolonged diarrhea. However, further studies are needed before these therapies can be recommended for all patients. • The most dramatic effect on disease activity has been observed in countries in which rotavirus vaccination has been incorporated. These vaccines have been shown to be effective and safe. • Widespread vaccination will continue to alter the epidemiology of the disease and will prevent many hospitalizations and save many lives.",
author = "Elaine Cox and John Christenson",
year = "2012",
month = "10",
doi = "10.1542/pir.33-10-439",
language = "English",
volume = "33",
pages = "439--447",
journal = "Pediatrics in Review",
issn = "0191-9601",
publisher = "American Academy of Pediatrics",
number = "10",

}

TY - JOUR

T1 - Rotavirus

AU - Cox, Elaine

AU - Christenson, John

PY - 2012/10

Y1 - 2012/10

N2 - • Rotavirus is a leading cause of gastroenteritis worldwide. The greatest morbidity and mortality is observed among young infants in the developing world. • Fever, vomiting, and diarrhea are the most common signs and symptoms of the disease. • Although highly sensitive and specific antigen assays are commercially available, most diagnoses can be made based on clinical manifestations and will not require diagnostic testing. • Treatment is supportive, with special attention to be placed on the replacement of fluids. In most instances, this goal can be achieved through the use of oral rehydration solutions. • The use of probiotics, oral immunoglobulins, and nitazoxanide has been shown in some studies to be of benefit in children with prolonged diarrhea. However, further studies are needed before these therapies can be recommended for all patients. • The most dramatic effect on disease activity has been observed in countries in which rotavirus vaccination has been incorporated. These vaccines have been shown to be effective and safe. • Widespread vaccination will continue to alter the epidemiology of the disease and will prevent many hospitalizations and save many lives.

AB - • Rotavirus is a leading cause of gastroenteritis worldwide. The greatest morbidity and mortality is observed among young infants in the developing world. • Fever, vomiting, and diarrhea are the most common signs and symptoms of the disease. • Although highly sensitive and specific antigen assays are commercially available, most diagnoses can be made based on clinical manifestations and will not require diagnostic testing. • Treatment is supportive, with special attention to be placed on the replacement of fluids. In most instances, this goal can be achieved through the use of oral rehydration solutions. • The use of probiotics, oral immunoglobulins, and nitazoxanide has been shown in some studies to be of benefit in children with prolonged diarrhea. However, further studies are needed before these therapies can be recommended for all patients. • The most dramatic effect on disease activity has been observed in countries in which rotavirus vaccination has been incorporated. These vaccines have been shown to be effective and safe. • Widespread vaccination will continue to alter the epidemiology of the disease and will prevent many hospitalizations and save many lives.

UR - http://www.scopus.com/inward/record.url?scp=84867374951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867374951&partnerID=8YFLogxK

U2 - 10.1542/pir.33-10-439

DO - 10.1542/pir.33-10-439

M3 - Article

C2 - 23027598

AN - SCOPUS:84867374951

VL - 33

SP - 439

EP - 447

JO - Pediatrics in Review

JF - Pediatrics in Review

SN - 0191-9601

IS - 10

ER -